Skip to content

Effect of Quercetin in Prevention and Treatment of Oral Mucositis

Effect of Quercetin in Prevention and Treatment of Chemotherapy Induced Oral Mucositis in Blood Dyscrasias

Status
Completed
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01732393
Enrollment
20
Registered
2012-11-22
Start date
2010-01-31
Completion date
2012-01-31
Last updated
2012-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chemotherapy Induced Oral Mucositis

Keywords

Quercetin, Chemotherapy, Mucositis, Hematologic Malignancies

Brief summary

The study aims to evaluate the effect of Quercetin (a natural flavonoid) on prevention of and treatment of chemotherapy-induced oral mucositis in patients with blood malignancies.

Interventions

DRUGoral quercetin capsules

10 cases in case group and 10 cases in control group. Patients in the intervention group were administered two, 250 mg Quercetin capsules daily for 3 weeks. Patients in the placebo group received two placebo capsules containing lactose .Patients were examined every other day for evaluation of initiation and severity of oral mucositis.

DRUGPlacebo

Sponsors

Mashhad University of Medical Sciences
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* patient under chemotherapy * for a hematologic malignancy * the hematologist permits the trial on the patient * agreement of patient for participating in the trial

Exclusion criteria

* presence pf ANY oral lesion at the beginning of the trial * loss of follow up * use of digoxin and cyclosporine * patient death

Design outcomes

Primary

MeasureTime frameDescription
lower grade of mucositis3 weeksgrade of mucositis due to WHO criteria

Secondary

MeasureTime frameDescription
duration of mucositis3 weeks of study tiem span and after trialduration of mucositis due to Who criteria

Countries

Iran

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026